Atypical Lymphoid Proliferations - Medscape
Table 2. Distinction between atypical lymphoid proliferations rich in Reed–Sternberg-like cells (reactive immunoblasts) and classic Hodgkin lymphomas.
An Update on Treatment Strategies for Common Variable
This disorder is the second most common primary immunodeficiency worldwide (after selective IgA deficiency) and the most common requiring immunoglobulin (Ig) replacement therapy.
Atypical Lymphoid Proliferations - Page 5 - Medscape
Atypical lymphoproliferative disorder, suggestive of lymphocyte-rich Hodgkin lymphoma but with insufficient features for definitive diagnosis. A 70-year-old female patient presented with a single ...
An Update on Treatment Strategies for Common Variable
Approximately 30% of CVID patients develop a nonmalignant lymphoproliferative disorder that may be manifested by splenomegaly, intestinal lymphoid hyperplasia or abdominal, mediastinal or ...
Posttransplantation Lymphoproliferative Disorder - Medscape
Feb 12, 2003 · A 53-year-old woman who had undergone a single right lung transplant in 2001 for COPD was admitted 1 year later with fatigue, dyspnea on exertion, and watery diarrhea.
Novel Monoclonal Antibodies for Lymphoproliferative Disorders
Cite this: Update on Novel Monoclonal Antibodies and Immunoconjugates for the Treatment of Lymphoproliferative Disorders - Medscape - Aug 01, 2011. Abstract and Introduction CD20 Target Antigen
Atypical Lymphoid Proliferations - Page 4 - Medscape
Traditionally, the lymphoproliferative lesions can be separated into two categories; benign (reactive lymphoid hyperplasia and lymphadenitis) and neoplastic (malignant lymphoma) conditions. [ 11 ...
Epidemiology, Etiology, Diagnosis, and Prognosis - Page 6
Cite this: Update on Bipolar Disorder: Epidemiology, Etiology, Diagnosis, and Prognosis - Medscape - Jun 13, 1997. Abstract & Introduction Manifestations of Bipolar Disorder
Characteristics of Systemic Diseases in the Breast - Page 3
Saturday, January 27, 2024. News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point Drugs & Diseases CME & Education Academy Video Decision Point
Bendamustine in B-Cell Lymphoproliferative Disorders - Medscape
Retherapy With Bendamustine in Indolent B-Cell Lymphoproliferative Disorders. Marco Montillo; Alessandra Tedeschi. Disclosures. Expert Rev Hematol. 2013;6(3):247-250. In This Article.